other material
confidence high
sentiment negative
materiality 0.65
Bone Biologics prices $5M underwritten public offering of 2.5M shares at $1.97/share
Bone Biologics Corp
- Gross proceeds of approximately $5.0 million from sale of 2,538,071 shares of common stock at $1.97 per share.
- Underwriters granted 45-day over-allotment option to purchase up to 253,807 additional shares.
- Offering expected to close on or about June 16, 2023, subject to customary conditions.
- EF Hutton, division of Benchmark Investments, acting as sole book-running manager.
- Registration statement on Form S-1 (No. 333-271558) declared effective by SEC on June 14, 2023.